GAD1

gene product
GAD
This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantigen and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Deficiency in this enzyme has been shown to lead to pyridoxine dependency with seizures. Alternative splicing of this gene results in two products, the predominant 67-kD form and a less-frequent 25-kD form. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
220 antibodies from 25 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
GeneTex
13 antibodies
Novus Biologicals
18 antibodies
OriGene
3 antibodies
Acris Antibodies GmbH
13 antibodies
antibodies-online
66 antibodies
Thermo Fisher Scientific Pierce
7 antibodies
R&D Systems
3 antibodies
Abnova Corporation
10 antibodies
Atlas Antibodies
1 antibody
Boster Immunoleader Biotechnology
1 antibody
Santa Cruz Biotechnology
1 antibody
LifeSpan BioSciences, Inc.
23 antibodies
Signalway Antibody LLC
2 antibodies
Everest Biotech
2 antibodies
Aviva Systems Biology
7 antibodies
Creative Biomart
26 antibodies
RabMAbs
3 antibodies
Abbiotec
1 antibody
Spring Bioscience
4 antibodies
GenWay
1 antibody
United States Biological
9 antibodies
EMD Millipore
1 antibody
Sigma-Aldrich
3 antibodies
Cell Signaling Technology, Inc
1 antibody
Proteintech Group
1 antibody